D-0186-2020 Class II Terminated
FDA drug recall D-0186-2020 was initiated by Mylan Pharmaceuticals Inc. on October 23, 2019 and is designated Class II. Reason for recall: Presence of Foreign Substance The recall status is terminated (terminated December 10, 2020). Affected quantity: 5,760 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- November 13, 2019
- Initiation Date
- October 23, 2019
- Termination Date
- December 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,760 bottles
Product Description
Alprazolam Tablets, USP 0.5 mg, 500-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 Made in Australia, NDC 0378-4003-05
Reason for Recall
Presence of Foreign Substance
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 8082708, Exp. Date September 2020